Head-to-Head Comparison Finds Three Anti-Seizure Drugs Equally Effective for Severe Form of Epilepsy
A new clinical trial in the emergency department finds no difference in efficacy or adverse effects of three commonly used treatments for patients with refractory status epilepticus.
Michigan Medicine researchers examined how a clinical trial on one drug’s efficacy affected its use in ambulances across the country.
Every year, 1 in 1,000 people with epilepsy dies suddenly. Scientists are using stem cells from children with rare seizure disorders to find answers and potentially guide treatment.